Helmholtz Gemeinschaft

Search
Browse
Statistics
Feeds

Recent technological updates and clinical applications of induced pluripotent stem cells

[thumbnail of Original Article]
Preview
PDF (Original Article) - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
1MB

Item Type:Review
Title:Recent technological updates and clinical applications of induced pluripotent stem cells
Creators Name:Diecke, S., Jung, S.M., Lee, J. and Ju, J.H.
Abstract:Induced pluripotent stem cells (iPSCs) were first described in 2006 and have since emerged as a promising cell source for clinical applications. The rapid progression in iPSC technology is still ongoing and directed toward increasing the efficacy of iPSC production and reducing the immunogenic and tumorigenic potential of these cells. Enormous efforts have been made to apply iPSC-based technology in the clinic, for drug screening approaches and cell replacement therapy. Moreover, disease modeling using patient-specific iPSCs continues to expand our knowledge regarding the pathophysiology and prospective treatment of rare disorders. Furthermore, autologous stem cell therapy with patient-specific iPSCs shows great propensity for the minimization of immune reactions and the provision of a limitless supply of cells for transplantation. In this review, we discuss the recent updates in iPSC technology and the use of iPSCs in disease modeling and regenerative medicine.
Keywords:Induced Pluripotent Stem Cells, Reprogramming Technique, Gene Editing, Disease Model, Regenerative Medicine, Animals, Mice
Source:Korean Journal of Internal Medicine
ISSN:1226-3303
Publisher:Korean Assoc Internal Medicine
Volume:29
Number:5
Page Range:547-57
Date:September 2014
Official Publication:https://doi.org/10.3904/kjim.2014.29.5.547
PubMed:View item in PubMed

Repository Staff Only: item control page

Downloads

Downloads per month over past year

Open Access
MDC Library